tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LYRA Stock Latest News

Cautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
RatingsCautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
1M ago
LYRA
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
PremiumCompany Announcements
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
1M ago
LYRA
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
PremiumThe Fly
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
1M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LYRA Upcoming Earnings Report: What to Expect?
1M ago
LYRA
Lyra Therapeutics announces clinical plan for LYR-210
PremiumThe Fly
Lyra Therapeutics announces clinical plan for LYR-210
2M ago
LYRA
Lyra Therapeutics Posts Corporate Presentation on LYR-210
PremiumCompany AnnouncementsLyra Therapeutics Posts Corporate Presentation on LYR-210
3M ago
8K
LYRA
Lyra Therapeutics Receives Nasdaq Deficiency Letter
Premium
Company Announcements
Lyra Therapeutics Receives Nasdaq Deficiency Letter
4M ago
8K
LYRA
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
Premium
Ratings
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
4M ago
LYRA
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
PremiumCompany Announcements
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
4M ago
LYRA
Lyra Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Lyra Therapeutics Reports Q2 2025 Financial Results
4M ago
LYRA
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
PremiumThe Fly
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
4M ago
LYRA
Is LYRA a Buy, Before Earnings?
PremiumPre-Earnings
Is LYRA a Buy, Before Earnings?
4M ago
LYRA
Lyra Therapeutics Announces Leadership Changes in August 2025
PremiumCompany AnnouncementsLyra Therapeutics Announces Leadership Changes in August 2025
5M ago
8K
LYRA
Lyra Therapeutics files to sell 846,744 shares of common stock for holders
Premium
The Fly
Lyra Therapeutics files to sell 846,744 shares of common stock for holders
5M ago
LYRA
Lyra Therapeutics Secures $4.3M in Direct Offering
Premium
Company Announcements
Lyra Therapeutics Secures $4.3M in Direct Offering
6M ago
8K
LYRA
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
PremiumCompany Announcements
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
6M ago
8K
LYRA
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
PremiumThe Fly
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
6M ago
LYRA
Lyra Therapeutics Unveils Strategic Plans for LYR-210
PremiumCompany Announcements
Lyra Therapeutics Unveils Strategic Plans for LYR-210
6M ago
8K
LYRA
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
7M ago
DG
CLF
Lyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results
PremiumMarket NewsLyra Therapeutics Stock (LYRA) Rockets 530% on Phase 3 Trial Results
7M ago
LYRA
Lyra Therapeutics Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Lyra Therapeutics Announces Positive Phase 3 Trial Results
7M ago
8K
LYRA
Lyra Therapeutics says ENLIGHTEN 2 trial of LYR-210 met primary endpoint
Premium
The Fly
Lyra Therapeutics says ENLIGHTEN 2 trial of LYR-210 met primary endpoint
7M ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >